4-(4-(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethoxy)benzylideneamino)-N-(thiazol-2-yl)benzenesulfonamide

ID: ALA4876707

PubChem CID: 164628252

Max Phase: Preclinical

Molecular Formula: C22H20N6O5S2

Molecular Weight: 512.57

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ncc([N+](=O)[O-])n1CCOc1ccc(/C=N\c2ccc(S(=O)(=O)Nc3nccs3)cc2)cc1

Standard InChI:  InChI=1S/C22H20N6O5S2/c1-16-24-15-21(28(29)30)27(16)11-12-33-19-6-2-17(3-7-19)14-25-18-4-8-20(9-5-18)35(31,32)26-22-23-10-13-34-22/h2-10,13-15H,11-12H2,1H3,(H,23,26)/b25-14-

Standard InChI Key:  UZNUPNIWZCXGKL-QFEZKATASA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    7.4874   -6.7458    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3124   -6.7458    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.8999   -6.0313    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0375   -6.7457    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7067   -6.2632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4500   -5.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6250   -5.4750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3681   -6.2632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5839   -6.5193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4960   -6.5190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1099   -5.9679    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6663   -7.3263    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0375   -7.5707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7519   -7.9832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7519   -8.8082    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4664   -9.2207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4639  -10.0468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1774  -10.4592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8929  -10.0467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8902   -9.2174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1761   -8.8087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6079  -10.4582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3218  -10.0448    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3208   -9.2198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0342   -8.8098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0334   -7.9856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3178   -7.5732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6016   -7.9911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6059   -8.8139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0291   -6.3338    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0268   -5.5088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6935   -5.0266    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.4365   -4.2427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6115   -4.2449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3588   -5.0303    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  7  8  2  0
  5  6  2  0
  4  5  1  0
  6  7  1  0
  8  4  1  0
  8  9  1  0
 10 11  2  0
 10 12  1  0
  5 10  1  0
  4 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 27  2  1  0
  2 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 31  2  0
M  CHG  2  10   1  12  -1
M  END

Alternative Forms

  1. Parent:

    ALA4876707

    ---

Associated Targets(Human)

CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA9 Tclin Carbonic anhydrase IX (8255 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 512.57Molecular Weight (Monoisotopic): 512.0937AlogP: 4.19#Rotatable Bonds: 10
Polar Surface Area: 141.61Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 6.76CX Basic pKa: 3.04CX LogP: 3.58CX LogD: 3.02
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.19Np Likeness Score: -2.16

References

1. Patel OPS, Jesumoroti OJ, Legoabe LJ, Beteck RM..  (2021)  Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.,  210  [PMID:33234343] [10.1016/j.ejmech.2020.112994]

Source